Long-Term Liabilities (Annual)

Long-Term Liabilities: The sum of all non-current liabilities.

Surgery Partners, Inc. (SGRY) had Long-Term Liabilities of $4.07B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$3.11B
Net Income	$-168.10M
Cost of Goods Sold	$2.37B
Gross Profit	$745.60M
Operating Expenses	$2.77B
Operating Income	$348.80M
Non-Operating Income/Expense	$-201.70M
Pre-Tax Income	$147.10M
Normalized Pre-Tax Income	$147.10M
Income after Taxes	$12.50M
Income from Continuous Operations	$12.50M
Consolidated Net Income/Loss	$12.50M
Normalized Income after Taxes	$12.50M
EBIT	$368.30M
EBITDA	$520.90M
Weighted-Average Shares Outstanding (Basic)	126.12M
Weighted-Average Shares Outstanding (Diluted)	126.12M
Earnings per Share (EPS) (Basic)	$-1.33
Earnings per Share (EPS) (Diluted)	$-1.33
Balance Sheet Financials
Current Assets	$1.12B
Property, Plant, and Equipment	$1.09B
Long-Term Assets	$6.77B
Total Assets	$7.89B
Current Liabilities	$624.40M
Long-Term Debt	$3.27B
Long-Term Liabilities	$4.07B
Total Liabilities	$4.69B
Common Equity	$3.20B
Tangible Shareholders Equity	$-1.92B
Shareholders Equity	$3.20B
Common Shares Outstanding	127.11M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$300.10M
Cash Flow from Investing Activities	$-488.50M
Cash Flow from Financial Activities	$262.00M
Beginning Cash	$195.90M
End Cash	$269.50M
Increase/Decrease in Cash	$73.60M
Stock-Based Compensation	$33.30M
Common Stock Dividends Paid	$-170.50M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.79
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.51
Debt to Equity Ratio	1.05
Gross Margin	23.94%
Operating Margin	11.20%
EBIT Margin	11.83%
EBITDA Margin	16.73%
Pre-Tax Profit Margin	4.72%
Profit Margin	-5.40%
Free Cash Flow	$212.30M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.39
Inventory Turnover	26.80
Receiveable Turnover	5.38
Days Sales in Receivables	67.87
Return on Equity	0.39%
Return on Tangible Equity	-0.65%
Return on Assets	0.16%
Return on Investments	0.19%
Book Value Per Share	$25.15
Free Cash Flow per Share	$1.68
Operating Cash Flow per Share	$2.38

Data from Zacks Investment Research, Inc.